Publication

Using Electronic Health Record Data to Rapidly Identify Children with Glomerular Disease for Clinical Research


Significance Statement
Clinical advances in glomerular disease have been stymied by the rarity of these health conditions, making identification of sufficient numbers of patients with glomerular disease for enrollment in research studies challenging, particularly in the pediatric setting. We leveraged the PEDSnet pediatric health system population of >6.5 million children to develop and evaluate a highly sensitive and specific electronic health record (EHR)–based computable phenotype algorithm to identify the largest cohort of children with glomerular disease to date. This tool for rapid cohort identification applied to a robust resource of multi-institutional longitudinal EHR data offers great potential to enhance and accelerate comparative effectiveness and health outcomes research in glomerular disease.

Background
The rarity of pediatric glomerular disease makes it difficult to identify sufficient numbers of participants for clinical trials. This leaves limited data to guide improvements in care for these patients.

Methods
The authors developed and tested an electronic health record (EHR) algorithm to identify children with glomerular disease. We used EHR data from 231 patients with glomerular disorders at a single center to develop a computerized algorithm comprising diagnosis, kidney biopsy, and transplant procedure codes. The algorithm was tested using PEDSnet, a national network of eight children’s hospitals with data on >6.5 million children. Patients with three or more nephrologist encounters (n=55,560) not meeting the computable phenotype definition of glomerular disease were defined as nonglomerular cases. A reviewer blinded to case status used a standardized form to review random samples of cases (n=800) and nonglomerular cases (n=798).

Results
The final algorithm consisted of two or more diagnosis codes from a qualifying list or one diagnosis code and a pretransplant biopsy. Performance characteristics among the population with three or more nephrology encounters were sensitivity, 96% (95% CI, 94% to 97%); specificity, 93% (95% CI, 91% to 94%); positive predictive value (PPV), 89% (95% CI, 86% to 91%); negative predictive value, 97% (95% CI, 96% to 98%); and area under the receiver operating characteristics curve, 94% (95% CI, 93% to 95%). Requiring that the sum of nephrotic syndrome diagnosis codes exceed that of glomerulonephritis codes identified children with nephrotic syndrome or biopsy-based minimal change nephropathy, FSGS, or membranous nephropathy, with 94% sensitivity and 92% PPV. The algorithm identified 6657 children with glomerular disease across PEDSnet, ≥50% of whom were seen within 18 months.

Conclusions
The authors developed an EHR-based algorithm and demonstrated that it had excellent classification accuracy across PEDSnet. This tool may enable faster identification of cohorts of pediatric patients with glomerular disease for observational or prospective studies.

Clinical Subject Headings

Studies

Description

Specifications

PEDSnet Project

P50 Projects: CHOP Pediatric Center for Excellence in Nephrology
Study Dates:2022 - PresentSponsor Site:Children's Hospital of Philadelphia
Funding towards the Pediatric Center of Excellence in Nephrology at the Children"s Hospital of Philadelphia (CHOP PCEN) to facilitate extensive collaborative research around the causes, diagnoses, and treatment of childhood kidney diseases.
Skeletal Outcomes in Children and Young Adults with Glomerular Disease
Study Dates:2018-09 - 2020-08Sponsor Site:Children's Hospital of Philadelphia
Study intended to identify disease-specific risk factors for fracture in children and adolescents; compare the rate and anatomic sites of fracture in children and adolescents with glomerular disease to healthy peers; determine the risk of slipped capital femoral epiphysis and osteonecrosis in children and adolescents with glomerular disease as compared to healthy peers; and determine the burden of patient-reported musculoskeletal complications.
Membranoproliferative Glomerulonephritis (MPGN) in PEDSnet
Study Dates:2019-06 - 2026-07Sponsor Site:Children's Hospital of Philadelphia
Project to identify and conduct phenotypic characterization of children with C3G and IC-MPGN in PEDSnet using data science and chart review methods. The long-term goal of this work is to perform a large multi-institutional natural history study, compare clinical outcomes in C3G and IC-MPGN, and identify predictors of disease response or progression.

Cite this Publication

Denburg MR, Razzaghi H, Bailey LC, Soranno DE, Pollack AH, Dharnidharka VR, Mitsnefes MM, Smoyer WE, Somers MJG, Zaritsky JJ, Flynn JT, Claes DJ, Dixon BP, Benton M, Mariani LH, Forrest CB, Furth SL. “Using Electronic Health Record Data to Rapidly Identify Children with Glomerular Disease for Clinical Research.” J Am Soc Nephrol. 2019 Dec;30(12):2427-2435. Epub 2019 Nov 15.
DOI: 10.1681/ASN.2019040365.
PMID: 31732612; PMCID: PMC6900784

Endorsement

Review

Supplemented By

Referenced By